Search for 'an:"1804"'

The Long-HER study: clinical and molecular analysis of patients with HER2+ advanced breast cancer who become long-term survivors with trastuzumab-based therapy.

By Manso Sánchez, Luis | Mendiola Fernández, César | Ciruelos Gil, Eva María. PLoS One, 2014 . 9(10):e109611. , Formato Vancouver: Gámez Pozo A, Pérez Carrión RM, Manso L, Crespo C, Mendiola C, López Vacas R et al. The Long-HER study: clinical and molecular analysis of patients with HER2+ advanced breast cancer who become long-term survivors with trastuzumab-based therapy. PLoS One. 2014 Oct 20;9(10):e109611.

Place Hold on The Long-HER study: clinical and molecular analysis of patients with HER2+ advanced breast cancer who become long-term survivors with trastuzumab-based therapy.

GEICO (Spanish Group for Investigation on Ovarian Cancer) treatment guidelines in ovarian cancer 2012.

By Mendiola Fernández, César. Clinical & Translational Oncology, 2013 . 15(7):509-25. , Formato Vancouver: González Martín A, Redondo A, Jurado M, De Juan A, Romero I, Bover I et al. GEICO (Spanish Group for Investigation on Ovarian Cancer) treatment guidelines in ovarian cancer 2012. Clin Transl Oncol. 2013 Jul;15(7):509-25.

Place Hold on GEICO (Spanish Group for Investigation on Ovarian Cancer) treatment guidelines in ovarian cancer 2012.

Safety and efficacy of metronomic non-pegylated liposomal encapsulated doxorubicin in heavily pretreated advanced breast cancer patients.

By Ciruelos Gil, Eva María | Cortés-Funes Castro, Hernán | Dorta Suárez, Myriam | Ghanem Cañete, Ismael | Manneh Kopp, Ray | Manso Sánchez, Luis | Mendiola Fernández, César | Sepúlveda Sánchez, Juan Manuel | Valdiviezo N, | Vega Alonso, Estela. Clinical & translational oncology: official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2013 . 15(6):467-71. , Formato Vancouver: Manso L, Valdiviezo N, Sepúlveda J, Ciruelos E, Mendiola C, Ghanem I, et al. Safety and efficacy of metronomic non-pegylated liposomal encapsulated doxorubicin in heavily pretreated advanced breast cancer patients. Clin Transl Oncol. 2013 Jun;15(6):467-71.

Place Hold on Safety and efficacy of metronomic non-pegylated liposomal encapsulated doxorubicin in heavily pretreated advanced breast cancer patients.

Fluorouracil, Doxorubicin, and Cyclophosphamide (FAC) Versus FAC Followed by Weekly Paclitaxel As Adjuvant Therapy for High-Risk, Node-Negative Breast Cancer: Results From the GEICAM/2003-02 Study.

By Mendiola Fernández, César. Journal of clinical oncology: official journal of the American Society of Clinical Oncology, 2013 . 31(20):2593-9. , Formato Vancouver: Martín M, Ruiz A, Ruiz Borrego M, Barnadas A, González S, Calvo L, et al. Fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus FAC followed by weekly paclitaxel as adjuvant therapy for high-risk, node-negative breast cancer: results from the GEICAM/2003-02 study. J Clin Oncol. 2013;31(20):2593–259.

Place Hold on Fluorouracil, Doxorubicin, and Cyclophosphamide (FAC) Versus FAC Followed by Weekly Paclitaxel As Adjuvant Therapy for High-Risk, Node-Negative Breast Cancer: Results From the GEICAM/2003-02 Study.

Cáncer de ovario

By Mendiola Fernández, César. Madrid: Grupo Aula Médica, 1999 . p. 821-864 , Formato Vancouver: Mendiola C, Gómez H, Martínez Salmeán J, Martín LF, Ojeda B. Cáncer de ovario. En: Cortés-Funes H, Díaz-Rubio E, García Conde J, Germà Lluch JR, Guillem Porta V, López López JJ, et al., editores. Oncología médica. Madrid: Grupo Aula Médica, 1999. p. 821-64.

Place Hold on Cáncer de ovario

Manual de oncología médica

By Cortés-Funes Castro, Hernán | Mendiola Fernández, César | Gómez Embuena, Adolfo. Barcelona: Masson, 1983 . 1059 p. ; , Formato Vancouver: Bonadonna G, Robustelli della Cuna G. Manual de oncología médica. Barcelona. Masson; 1983. 26 cm..

Place Hold on Manual de oncología médica